Companies /Healthcare

Novartis AG ADR

NYSE: NVS Drug Manufacturers - General
$160.50
▲ $0.25 (+0.16%) today
Markets closed · 2:03pm ET

NVS Coverage Page 4

8:25am ET
Health and Healthcare

Novartis Gambles $8.7 Billion on Gene-Therapy Firm

Swiss drug maker Novartis has agreed to acquire U.S.-based AveXis for $8.7 billion in cash. AveXis is developing a gene-therapy to treat an inherited disease to treat the leading cause of gene-related…

NVS
Paul Ausick